Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NUCLEUS.NS Stock Summary
Top 10 Correlated ETFs
NUCLEUS.NS
In the News
NUCLEUS.NS Financial details
Company Rating
Neutral
Market Cap
32.65B
Income
2.07B
Revenue
8.22B
Book val./share
-
Cash/share
-
Dividend
10
Dividend %
0.68%
Employees
1.78K
Optionable
No
Shortable
Yes
Earnings
24 May 2024
P/E
19.4
Forward P/E
13.48
PEG
0.44
P/S
5.03
P/B
5.75
P/C
-
P/FCF
-
Quick Ratio
1.54
Current Ratio
2.26
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
77.35
EPS next Y
87.9
EPS next Q
16.8
EPS this Y
234.24%
EPS next Y
13.64%
EPS next 5Y
39.24%
EPS last 5Y
13.21%
Revenue last 5Y
5.56%
Revenue Q/Q
-0.55%
EPS Q/Q
-7.33%
-
-
-
-
SMA20
-13.4%
SMA50
-22.03%
SMA100
-23.19%
Inst Own
-
Inst Trans
-
ROA
20%
ROE
63%
ROC
0.36%
Gross Margin
43%
Oper. Margin
33%
Profit Margin
26%
Payout
-
Shs Outstand
26.77M
Shs Float
7.13M
-
-
-
-
Target Price
-
52W Range
574.65-1787.5
52W High
-33.69%
52W Low
+106.43%
RSI
36
Rel Volume
1.04
Avg Volume
26.77K
Volume
27.9K
Perf Week
0.58%
Perf Month
-15.32%
Perf Quarter
13.84%
Perf Half Y
21.56%
-
-
-
-
Beta
0.346
-
-
Volatility
23.03%, 94.56%
Prev Close
-2.23%
Price
1184.9
Change
-4.37%
NUCLEUS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 166.67 | 179.34 | 176.83 | 173.58 | 236.97 | |
Net income per share | 25.67 | 30.64 | 40.62 | 14.28 | 47.73 | |
Operating cash flow per share | 19.31 | 25.73 | 39.57 | 20.13 | 18.62 | |
Free cash flow per share | 16.3 | 21.46 | 38.54 | 11.67 | 17.23 | |
Cash per share | 89.05 | 113.8 | 172.53 | 119.04 | 103.98 | |
Book value per share | 175.12 | 193.14 | 231.41 | 172.33 | 228.09 | |
Tangible book value per share | 174.26 | 192.33 | 230.96 | 169.82 | 227.03 | |
Share holders equity per share | 175.12 | 193.14 | 231.41 | 172.33 | 228.09 | |
Interest debt per share | -34.84 | 2.41 | 2.45 | 0.97 | 2.72 | |
Market cap | 9.8B | 5.22B | 13.97B | 11.86B | 17.12B | |
Enterprise value | 9.36B | 4.72B | 13.72B | 11.54B | 16.67B | |
P/E ratio | 13.15 | 5.86 | 11.85 | 29 | 13.39 | |
Price to sales ratio | 2.03 | 1 | 2.72 | 2.39 | 2.7 | |
POCF ratio | 17.48 | 6.98 | 12.16 | 20.57 | 34.34 | |
PFCF ratio | 20.71 | 8.37 | 12.49 | 35.49 | 37.1 | |
P/B Ratio | 1.93 | 0.93 | 2.08 | 2.4 | 2.8 | |
PTB ratio | 1.93 | 0.93 | 2.08 | 2.4 | 2.8 | |
EV to sales | 1.93 | 0.91 | 2.67 | 2.32 | 2.63 | |
Enterprise value over EBITDA | 8.68 | 3.63 | 9.59 | 22.83 | 8.74 | |
EV to operating cash flow | 16.68 | 6.32 | 11.94 | 20 | 33.45 | |
EV to free cash flow | 19.77 | 7.58 | 12.26 | 34.51 | 36.14 | |
Earnings yield | 0.08 | 0.17 | 0.08 | 0.03 | 0.07 | |
Free cash flow yield | 0.05 | 0.12 | 0.08 | 0.03 | 0.03 | |
Debt to equity | -0.2 | 0.01 | 0.01 | 0 | 0.01 | |
Debt to assets | -0.15 | 0.01 | 0.01 | 0 | 0.01 | |
Net debt to EBITDA | -0.41 | -0.38 | -0.18 | -0.65 | -0.23 | |
Current ratio | 2.13 | 2.36 | 3.11 | 2.09 | 2.07 | |
Interest coverage | 0 | 119.62 | 142.56 | 49.2 | 135.33 | |
Income quality | 0.58 | 0.64 | 0.75 | 1.04 | 0.29 | |
Dividend Yield | 0.03 | 0.06 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.35 | 0.33 | 0.07 | 0.43 | 0.15 | |
Sales general and administrative to revenue | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | |
Research and developement to revenue | 0.67 | 0.66 | 0.65 | 0.78 | 0.64 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0 | |
Capex to operating cash flow | -0.16 | -0.17 | -0.03 | -0.42 | -0.07 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.05 | -0.01 | |
Capex to depreciation | -0.88 | -0.92 | -0.22 | -1.58 | -0.2 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 318.01 | 364.91 | 459.86 | 235.33 | 494.92 | |
ROIC | 0.14 | 0.11 | 0.13 | 0.03 | 0.17 | |
Return on tangible assets | 0.11 | 0.12 | 0.13 | 0.06 | 0.15 | |
Graham Net | 34.48 | 72.85 | 127.83 | 62.89 | 55.96 | |
Working capital | 1.91B | 2.57B | 4.17B | 2.38B | 2.5B | |
Tangible asset value | 5.06B | 5.59B | 6.71B | 4.86B | 6.08B | |
Net current asset value | 1.83B | 2.43B | 4.02B | 2.12B | 2.2B | |
Invested capital | -0.2 | 0.01 | 0.01 | 0 | 0.01 | |
Average receivables | 367.2M | 888.85M | 1.04B | 1.02B | 1.45B | |
Average payables | 331.6M | 136.45M | 140.3M | 136.5M | 132.75M | |
Average inventory | -367.2M | -313.8M | 106.1M | 117.5M | -7.5M | |
Days sales outstanding | 55.38 | 73.11 | 73.49 | 74.4 | 109.07 | |
Days payables outstanding | 228.19 | 229.35 | 267.34 | 12.38 | 11.19 | |
Days of inventory on hand | -1.37K | 162.97 | 216.25 | 11.24 | -13.17 | |
Receivables turnover | 6.59 | 4.99 | 4.97 | 4.91 | 3.35 | |
Payables turnover | 1.6 | 1.59 | 1.37 | 29.48 | 32.62 | |
Inventory turnover | -0.27 | 2.24 | 1.69 | 32.46 | -27.71 | |
ROE | 0.15 | 0.16 | 0.18 | 0.08 | 0.21 | |
Capex per share | -3.01 | -4.28 | -1.03 | -8.46 | -1.38 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 63.25 | 77.04 | 77.24 | 76.66 | 76.25 | |
Net income per share | 14.32 | 25.28 | 20 | 16.65 | 15.43 | |
Operating cash flow per share | 3.68 | 2.7 | 2.71 | 2.7 | 2.63 | |
Free cash flow per share | 3.68 | 2.7 | 2.71 | 2.7 | 2.63 | |
Cash per share | 0 | 104.02 | 0 | 155.77 | 0 | |
Book value per share | 0 | 228.17 | 0 | 257.24 | 0 | |
Tangible book value per share | 0 | 227.11 | 0 | 256.28 | 0 | |
Share holders equity per share | 0 | 228.17 | 0 | 257.24 | 0 | |
Interest debt per share | 0.1 | 2.44 | 0.09 | 2.24 | 0.08 | |
Market cap | 10.3B | 17.11B | 28.74B | 26.83B | 38.43B | |
Enterprise value | 10.3B | 16.67B | 28.74B | 26.24B | 38.43B | |
P/E ratio | 6.72 | 6.32 | 13.41 | 15.04 | 23.26 | |
Price to sales ratio | 6.08 | 8.3 | 13.9 | 13.07 | 18.83 | |
POCF ratio | 104.45 | 236.98 | 395.85 | 371.62 | 545.89 | |
PFCF ratio | 104.45 | 236.98 | 395.85 | 371.62 | 545.89 | |
P/B Ratio | 0 | 2.8 | 0 | 3.9 | 0 | |
PTB ratio | 0 | 2.8 | 0 | 3.9 | 0 | |
EV to sales | 6.08 | 8.08 | 13.9 | 12.78 | 18.83 | |
Enterprise value over EBITDA | 18.01 | 18.03 | 38.11 | 41.13 | 64.43 | |
EV to operating cash flow | 104.45 | 230.86 | 395.85 | 363.42 | 545.89 | |
EV to free cash flow | 104.45 | 230.86 | 395.85 | 363.42 | 545.89 | |
Earnings yield | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.01 | 0 | 0.01 | 0 | |
Debt to assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Net debt to EBITDA | 0 | -0.48 | 0 | -0.93 | 0 | |
Current ratio | 0 | 2.07 | 0 | 2.26 | 0 | |
Interest coverage | 201 | 341.77 | 235.8 | 231.5 | 267.29 | |
Income quality | 0.26 | 0.11 | 0.14 | 0.16 | 0.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.08 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 1.97 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 360.23 | 0 | 310.47 | 0 | |
ROIC | 0 | 0.11 | 0 | 0.06 | 0 | |
Return on tangible assets | 0 | 0.08 | 0 | 0.04 | 0 | |
Graham Net | 0 | 55.98 | 0 | 85.21 | 0 | |
Working capital | 3.6B | 2.5B | 2.77B | 3.41B | 0 | |
Tangible asset value | 0 | 6.08B | 0 | 6.86B | 0 | |
Net current asset value | 3.6B | 2.2B | 2.77B | 3.02B | 0 | |
Invested capital | 0 | 0.01 | 0 | 0.01 | 0 | |
Average receivables | 367.5M | 947.95M | 947.95M | 810.65M | 810.65M | |
Average payables | 59.65M | 61.4M | 61.4M | 67.9M | 67.9M | |
Average inventory | 1.15M | -72.3M | -72.3M | 0 | 0 | |
Days sales outstanding | 0 | 82.75 | 0 | 71.09 | 0 | |
Days payables outstanding | 0 | 10.23 | 0 | 9.94 | 0 | |
Days of inventory on hand | 0 | -12.05 | 0 | 0 | 0 | |
Receivables turnover | 0 | 1.09 | 0 | 1.27 | 0 | |
Payables turnover | 0 | 8.8 | 0 | 9.05 | 0 | |
Inventory turnover | 0 | -7.47 | 0 | 0 | 0 | |
ROE | 0 | 0.11 | 0 | 0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NUCLEUS.NS Frequently Asked Questions
What is Nucleus Software Exports Limited stock symbol ?
Nucleus Software Exports Limited is a IN stock and trading under the symbol NUCLEUS.NS
What is Nucleus Software Exports Limited stock quote today ?
Nucleus Software Exports Limited stock price is $1184.9 today.
Is Nucleus Software Exports Limited stock public?
Yes, Nucleus Software Exports Limited is a publicly traded company.